Pfizer And BioNTech To Ask FDA To Authorize COVID-19 Booster For Kids As Young As 5
Pfizer and BioNTech plan to ask the Food and Drug Administration to clear a third dose of their COVID-19 vaccine for children as young as 5, the companies announced Wednesday, citing trial results showing a "robust response" of antibodies in this age group after the booster shot. In the trial,...